Performances of a novel chemiluninescence ABEI-based NT-proBNP immunoassay.
Christina AdamantidouSylvie AhnMichel RousseauDamien GrusonPublished in: Acta cardiologica (2021)
Natriuretic peptides are widely used in clinical practice as cardiac markers for early diagnosis, prognosis and for the monitoring of treatment efficiency of heart Failure (HF). According to the clinical relevance of natriuretic peptides testing, it is important to assess the performances of novel platform for testing. Our study showed the overall good performances of a new NT-proBNP ABEI-based automated immunoassay.